Morgan Stanley analyst Joseph Moore maintains Advanced Micro Devices (NASDAQ:AMD) with a Overweight and raises the price target from $77 to $87.
Transcode Therapeutics Announced Publication Of An Open Letter To Shareholders Outlining The Company’s Progress In 2023 And Objectives In 2024
Dear Shareholders,As we begin the new year, we reflect on the challenges faced by the biotech sector over the past two years. Despite those challenges, we have the pleasure to report on TransCode's progress and
